Bile inhibits release of cholecystokinin and neurotensin
- PMID: 3738760
Bile inhibits release of cholecystokinin and neurotensin
Abstract
We have investigated the effect of bile on fat-stimulated release and basal plasma levels of cholecystokinin-33/39 (CCK) and neurotensin in six awake dogs prepared with chronic gastric and duodenal cannulas. Experimental bile diversion was achieved by catheterization of the common bile duct through the duodenal cannula; the gallbladder was undisturbed. Bile diversion significantly enhanced the release of both CCK and neurotensin that was stimulated by intraduodenal (ID) infusion of a triglyceride suspension (corn oil) (0.5 gm/kg-hr). The integrated release with ID triglyceride (ng [0 to 90 min]/ml) for CCK was control 5.58 +/- 0.83, bile diversion 14.47 +/- 2.81, bile excess 1.68 +/- 0.56, and for neurotensin was control 0.35 +/- 0.19, bile diversion 1.26 +/- 0.35, and bile excess 0.45 +/- 0.31. ID infusion of excessive bile (bile collected during bile diversion) significantly inhibited both the release and basal levels of CCK. Bile diversion alone did not modify plasma levels of CCK or neurotensin. We conclude that: endogenous bile exerts a negative feedback effect on release of CCK and neurotensin induced by triglyceride and on basal plasma levels of CCK; bile is unnecessary for the stimulation of endocrine cells in the intestinal mucosa by dietary fat; and measured basal levels of CCK and neurotensin represent a real amount of circulating peptide in the fasting state, that is, the basal levels are real and not artifactual.
Similar articles
-
Influence of different anesthetic agents on the release of cholecystokinin in dogs.Surgery. 1985 Apr;97(4):415-9. Surgery. 1985. PMID: 3983816
-
Role of neurotensin in pancreatic secretion.Surgery. 1984 Aug;96(2):146-53. Surgery. 1984. PMID: 6463855
-
Importance of the ileum in neurotensin released by fat.Surgery. 1985 Aug;98(2):224-9. Surgery. 1985. PMID: 4023920
-
Effect of total jejunoileal denervation on fat-stimulated release of peptide YY and cholecystokinin.Surgery. 1990 Aug;108(2):248-52; discussion 252-3. Surgery. 1990. PMID: 2382224
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
Cited by
-
Effect of cholestyramine and cholecystokinin receptor antagonist CR1505 (loxiglumide) on lower esophageal sphincter pressure in man.Dig Dis Sci. 1993 Oct;38(10):1889-92. doi: 10.1007/BF01296114. Dig Dis Sci. 1993. PMID: 8404410
-
Bile acids in human plasma interfere with cholecystokinin bioassay using dispersed pancreatic acini.Dig Dis Sci. 1991 Mar;36(3):310-6. doi: 10.1007/BF01318202. Dig Dis Sci. 1991. PMID: 1995267
-
Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones.Ann Surg. 1987 Jun;205(6):641-8. doi: 10.1097/00000658-198706000-00005. Ann Surg. 1987. PMID: 3592806 Free PMC article.
-
Cholelithiasis and cholecystectomy increase the risk of gastroesophageal reflux disease and Barrett's esophagus.Front Med (Lausanne). 2024 Jul 18;11:1420462. doi: 10.3389/fmed.2024.1420462. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39091288 Free PMC article.
-
Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.Dig Dis Sci. 1991 Nov;36(11):1625-32. doi: 10.1007/BF01296408. Dig Dis Sci. 1991. PMID: 1935502